Alnylam Pharmaceuticals, Inc.
2017 Q1 - 2025 Q4 (36 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 4,990 | 0.0% | 12,549 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 6,670 | 0.0% | 14,627 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 2,464 | 0.0% | 7,549 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 2,545 | 0.0% | 9,422 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 2,135 | 0.0% | 9,081 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 5,172 | 0.0% | 18,816 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 3,883 | 0.0% | 15,981 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 3,167 | 0.0% | 16,685 | 3/31/2024 |
| 2023 Q4 | 8/15/2024 | 3,070 | 0.0% | 16,039 | 12/31/2023 |
| 2023 Q3 | 8/15/2024 | 2,841 | 0.0% | 16,039 | 9/30/2023 |
| 2023 Q2 | 8/15/2024 | 3,268 | 0.0% | 17,206 | 6/30/2023 |
| 2023 Q1 | 8/15/2024 | 5,464 | 0.1% | 27,275 | 3/31/2023 |
| 2022 Q4 | 8/15/2024 | 8,009 | 0.1% | 33,699 | 12/31/2022 |
| 2022 Q3 | 8/15/2024 | 6,745 | 0.1% | 33,699 | 9/30/2022 |
| 2022 Q2 | 8/15/2024 | 5,033 | 0.1% | 34,505 | 6/30/2022 |
| 2022 Q1 | 8/15/2024 | 5,482 | 0.1% | 33,575 | 3/31/2022 |
| 2021 Q4 | 8/30/2024 | 5,499 | 0.1% | 32,446 | 12/31/2021 |
| 2021 Q3 | 8/30/2024 | 6,415 | 0.1% | 34,015 | 9/30/2021 |
| 2021 Q2 | 8/30/2024 | 6,028 | 0.1% | 35,602 | 6/30/2021 |
| 2021 Q1 | 8/30/2024 | 5,135 | 0.1% | 36,347 | 3/31/2021 |
| 2020 Q4 | 8/30/2024 | 6,056 | 0.1% | 46,570 | 12/31/2020 |
| 2020 Q3 | 8/30/2024 | 7,552 | 0.1% | 51,729 | 9/30/2020 |
| 2020 Q2 | 8/30/2024 | 8,343 | 0.1% | 56,146 | 6/30/2020 |
| 2020 Q1 | 8/30/2024 | 6,549 | 0.1% | 59,457 | 3/31/2020 |
| 2019 Q4 | 8/30/2024 | 6,840 | 0.1% | 59,457 | 12/31/2019 |
| 2019 Q3 | 8/30/2024 | 4,520 | 0.1% | 56,187 | 9/30/2019 |
| 2019 Q2 | 8/30/2024 | 2,237 | 0.0% | 30,892 | 6/30/2019 |
| 2019 Q1 | 8/30/2024 | 2,887 | 0.0% | 30,892 | 3/31/2019 |
| 2018 Q4 | 8/30/2024 | 1,699 | 0.0% | 23,276 | 12/31/2018 |
| 2018 Q3 | 8/30/2024 | 2,040 | 0.0% | 23,276 | 9/30/2018 |
| 2018 Q2 | 8/30/2024 | 2,296 | 0.0% | 23,276 | 6/30/2018 |
| 2018 Q1 | 8/30/2024 | 2,774 | 0.0% | 23,276 | 3/31/2018 |
| 2017 Q4 | 8/30/2024 | 2,950 | 0.0% | 23,276 | 12/31/2017 |
| 2017 Q3 | 8/30/2024 | 2,741 | 0.0% | 23,276 | 9/30/2017 |
| 2017 Q2 | 8/30/2024 | 1,856 | 0.0% | 23,276 | 6/30/2017 |
| 2017 Q1 | 8/30/2024 | 1,374 | 0.0% | 26,812 | 3/31/2017 |